{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:43:39Z","timestamp":1759365819210,"version":"build-2065373602"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Changji\u2019an Formula (CJAF) is an effective Chinese herbal prescription to treat irritable bowel syndrome with predominant diarrhea (IBS-D), which is derived from two famous classical prescription: Sijunzi decoction and Tong-Xie-Yao-Fang. However, the molecular mechanism has not been well defined. This study aims to illustrate the molecular mechanism of CJAF in the treatment of IBS-D.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Chemical components of CJAF were determined by ultrahigh performance liquid chromatography-quadrupole\/orbitrap high resolution mass spectrometry (UPLC-Q-Orbitrap HRMS) and further verified by reference standards. IBS-D model was induced in C57BL\/6J mice by a single edema with colonic infusion of 0.1 mL trinitrobenzene sulfonic acid (TNBS, 50\u00a0mg\/mL) combined with 7 days of restraint stress, 2\u00a0h\/d. The treatment group was given rifaximin (100\u00a0mg\/kg) and high, moderate and low doses of CJAF by gavage for 7 days, respectively (<jats:italic>n<\/jats:italic>\u2009=\u20097). After administration, the main symptoms of IBS-D were tested, and behavioral tests were conducted using sucrose preference test and open field test. The colonic tissues of mice were obtained. Gene and protein expression of mast cell tryptase, nerve growth factor (NGF), tyrosine kinase receptor A (TrkA), phosphorylated TrkA, growth associated protein 43(GAP43) and neuro-specific enolase (NSE) were determined by RT-PCR, western blot and immunohistochemistry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>36 compounds were identified by UPLC-Q-Orbitrap HRMS, and the determined components can be categorized into 7 chemical types, including 16 flavonoids, 7 triterpenoids, 4 alkaloids, 3 sesquiterpenoids, 2 monoterpene glycosides, 2 organic acids, 1 phenylpropanoids and 1 tannin. Animal experiment showed that the abdominal pain and diarrhea symptoms of IBS-D mice were alleviated by CJAF. The sucrose preference, total translocation distance and average velocity of movement in the open field test was upregulated. The mRNA and protein expression of mast cell marker tryptase, as well as NGF, phosphorylated TrkA, GAP43 and NSE in IBS-D mice colonic tissues were down-regulated by CJAF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CJAF could effectively alleviate abdominal pain and diarrhea symptoms of IBS-D by inhibiting the activation of colonic mast cells and the resultant activation of NGF\/TrkA signal pathway. Therefore, CJAF affords a potential candidate for the treatment of IBS-D.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12906-025-05095-3","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:32:45Z","timestamp":1759314765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Changji\u2019an formula alleviates visceral hypersensitivity of a post-inflammatory IBS-D mouse model via NGF\/TrkA signaling pathway"],"prefix":"10.1186","volume":"25","author":[{"given":"Wei","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaiguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanghao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuncong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"5095_CR1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031","author":"F Mearin","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031.","journal-title":"Gastroenterology"},{"issue":"9","key":"5095_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920\u20134.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"5095_CR3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","volume":"10","author":"RM Lovell","year":"2012","unstructured":"Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"26","key":"5095_CR4","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.3748\/wjg.v21.i26.8103","volume":"21","author":"P Singh","year":"2015","unstructured":"Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, et al. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J Gastroenterol. 2015;21(26):8103\u20139.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"5095_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.5056\/jnm16001","volume":"22","author":"MH Farzaei","year":"2016","unstructured":"Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments. J Neurogastroenterol Motil. 2016;22(4):558\u201374.","journal-title":"J Neurogastroenterol Motil"},{"key":"5095_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320633","author":"T Van Uytsel","year":"2023","unstructured":"Van Uytsel T, Bercik P, Boeckxstaens G. Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders. Gut. 2023. https:\/\/doi.org\/10.1136\/gutjnl-2020-320633.","journal-title":"Gut"},{"issue":"6","key":"5095_CR7","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1053\/gast.2002.37059","volume":"123","author":"H T\u00f6rnblom","year":"2002","unstructured":"T\u00f6rnblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology. 2002;123(6):1972\u20139.","journal-title":"Gastroenterology"},{"issue":"5","key":"5095_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/gutjnl-2011-300265","volume":"61","author":"Y-B Yu","year":"2012","unstructured":"Yu Y-B, Zuo X-L, Zhao Q-J, Chen F-X, Yang J, Dong Y-Y, et al. Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut. 2012;61(5):685\u201394.","journal-title":"Gut"},{"issue":"3","key":"5095_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G Barbara","year":"2004","unstructured":"Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126(3):693\u2013702.","journal-title":"Gastroenterology"},{"issue":"1","key":"5095_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1631\/jzus.B1500181","volume":"17","author":"X-j Xu","year":"2016","unstructured":"Xu X-j, Liu L, Yao S-k. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? J Zhejiang Univ Sci B. 2016;17(1):1\u20139.","journal-title":"J Zhejiang Univ Sci B"},{"key":"5095_CR11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.01.042","author":"G Dothel","year":"2015","unstructured":"Dothel G, Barbaro MR, Boudin H, Vasina V, Cremon C, Gargano L, et al. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2015. https:\/\/doi.org\/10.1053\/j.gastro.2015.01.042.","journal-title":"Gastroenterology"},{"issue":"1","key":"5095_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-020-1708-9","volume":"17","author":"N Delivanoglou","year":"2020","unstructured":"Delivanoglou N, Boziki M, Theotokis P, Kesidou E, Touloumi O, Dafi N, et al. Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2020;17(1):41.","journal-title":"J Neuroinflammation"},{"issue":"14","key":"5095_CR13","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.yexcr.2007.06.002","volume":"313","author":"D Diolaiti","year":"2007","unstructured":"Diolaiti D, Bernardoni R, Trazzi S, Papa A, Porro A, Bono F, et al. Functional cooperation between TrkA and p75(NTR) accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP\/WAF) genes via ERK1\/2 and AP-1 activities. Exp Cell Res. 2007;313(14):2980\u201392.","journal-title":"Exp Cell Res"},{"issue":"2","key":"5095_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0166-2236(96)10072-2","volume":"20","author":"LI Benowitz","year":"1997","unstructured":"Benowitz LI, Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 1997;20(2):84\u201391.","journal-title":"Trends Neurosci"},{"issue":"9","key":"5095_CR15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.2015.0954","volume":"313","author":"WD Chey","year":"2015","unstructured":"Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949\u201358.","journal-title":"JAMA"},{"key":"5095_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114119","volume":"275","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chu F, Lin J, Su Z, Liao M, Li T, et al. The mechanisms of action of weichang\u2019an pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies. J Ethnopharmacol. 2021;275:114119.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"5095_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/apt.14817","volume":"48","author":"M Chen","year":"2018","unstructured":"Chen M, Tang TC, Wang Y, Shui J, Xiao XH, Lan X, et al. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48(2):160\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"5095_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1053103","volume":"13","author":"X Xia","year":"2022","unstructured":"Xia X, Xie Y, Chen Q, Ding D, Wang Z, Xu Y, et al. Cocultivation of Chinese prescription and intestine microbiota: sjzd alleviated the major symptoms of IBS-D subjects by tuning neurotransmitter metabolism. Front Endocrinol (Lausanne). 2022;13:1053103.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5095_CR19","doi-asserted-by":"crossref","unstructured":"Liu JP, Yang M, Liu YX, Wei ML, Grimsgaard S. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2006 ;(1):CD004116.","DOI":"10.1002\/14651858.CD004116.pub2"},{"issue":"19","key":"5095_CR20","first-page":"2614","volume":"26","author":"CF Fang","year":"2015","unstructured":"Fang CF, Tang HM, Liao XH, Huang H, Liu B. Study on the effect of changji\u2019an capsules on abdominal pain in Diarrhea-predominant irritable bowel syndrome model rats and its molecular mechanism. China Pharm. 2015;26(19):2614\u20137.","journal-title":"China Pharm"},{"key":"5095_CR21","first-page":"93","volume":"22","author":"YN Chai","year":"2016","unstructured":"Chai YN, Huang YS, Tang HM, Wang T, Liu Y, Zhong RF. Effect of shugan jianpi method (Changji\u2019an fomulation) on IBS-D immune function. Chin J Exp Tradit Med Formulae. 2016;22:93\u20138.","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"08","key":"5095_CR22","first-page":"505","volume":"27","author":"YS Huang","year":"2017","unstructured":"Huang YS, Liu Y, Zhong RF, Tang HM, Wang T, Shi YY, et al. The effect of changji\u2019 an prescription on JAK2 \/STAT3 signaling pathway of IBS-D rats. China Pharm. 2017;27(08):505\u20139.","journal-title":"China Pharm"},{"issue":"12","key":"5095_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33102","volume":"10","author":"W Ke","year":"2024","unstructured":"Ke W, Wu J, Li H, Huang S, Li H, Wang Y, et al. Network pharmacology and experimental validation to explore the mechanism of changji\u2019an formula against irritable bowel syndrome with predominant diarrhea. Heliyon. 2024;10(12):e33102.","journal-title":"Heliyon"},{"issue":"6","key":"5095_CR24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1053\/j.gastro.2016.08.003","volume":"151","author":"A Lembo","year":"2016","unstructured":"Lembo A, Pimentel M, Rao SS, Schoenfeld P, Cash B, Weinstock LB, et al. Repeat treatment with rifaximin is safe and effective in patients with Diarrhea-Predominant irritable bowel syndrome. Gastroenterology. 2016;151(6):1113\u201321.","journal-title":"Gastroenterology"},{"issue":"1","key":"5095_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22\u201332.","journal-title":"N Engl J Med"},{"issue":"6","key":"5095_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/aps.2014.170","volume":"36","author":"F-y Wang","year":"2015","unstructured":"Wang F-y, Su M, Zheng Y-q, Wang X-g, Kang N, Chen T, et al. Herbal prescription chang\u2019an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome. Acta Pharmacol Sin. 2015;36(6):708\u201315.","journal-title":"Acta Pharmacol Sin"},{"key":"5095_CR27","doi-asserted-by":"publisher","first-page":"843396","DOI":"10.3389\/fnins.2022.843396","volume":"16","author":"L Guan","year":"2022","unstructured":"Guan L, Shi X, Tang Y, Yan Y, Chen L, Chen Y, et al. Contribution of amygdala histone acetylation in early life stress-induced visceral hypersensitivity and emotional comorbidity. Front Neurosci. 2022;16:843396.","journal-title":"Front Neurosci"},{"issue":"07","key":"5095_CR28","first-page":"943","volume":"31","author":"QQ Zhang","year":"2018","unstructured":"Zhang QQ, Liu ZY, Zhong Y. Effect of bifico on 5-HT3 receptor expression in colonic mucosa of diarrhea predominant irritable bowel syndrome. Chin J Clin Res. 2018;31(07):943\u20136.","journal-title":"Chin J Clin Res"},{"issue":"11","key":"5095_CR29","first-page":"1191","volume":"33","author":"WG Wang","year":"2011","unstructured":"Wang WG, Liu ZZ, Wu WT, Wan YH, Yan HM. Application of open field test in mouse behavior analysis. Chin J Cell Biol. 2011;33(11):1191\u20136.","journal-title":"Chin J Cell Biol"},{"issue":"3","key":"5095_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/BF00187257","volume":"93","author":"P Willner","year":"1987","unstructured":"Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology. 1987;93(3):358\u201364.","journal-title":"Psychopharmacology"},{"key":"5095_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijbiomac.2013.09.038","volume":"62","author":"Y-x Mei","year":"2013","unstructured":"Mei Y-x, Chen H-x, Zhang J, Zhang X-d, Liang Y-x. Protective effect of chitooligosaccharides against cyclophosphamide-induced immunosuppression in mice. Int J Biol Macromol. 2013;62:330\u20135.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5095_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.14309\/ajg.0000000000000485","volume":"115","author":"NJ Talley","year":"2020","unstructured":"Talley NJ. What causes functional gastrointestinal disorders?? A proposed disease model. Am J Gastroenterol. 2020;115(1):41\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"5095_CR33","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","volume":"132","author":"T Liebregts","year":"2007","unstructured":"Liebregts T, Adam B, Bredack C, R\u00f6th A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132(3):913\u201320.","journal-title":"Gastroenterology"},{"issue":"2","key":"5095_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/ajg.2008.94","volume":"104","author":"C Cremon","year":"2009","unstructured":"Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104(2):392\u2013400.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"5095_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","volume":"132","author":"G Barbara","year":"2007","unstructured":"Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132(1):26\u201337.","journal-title":"Gastroenterology"},{"issue":"11","key":"5095_CR36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41577-022-00700-9","volume":"22","author":"J Aguilera-Lizarraga","year":"2022","unstructured":"Aguilera-Lizarraga J, Hussein H, Boeckxstaens GE. Immune activation in irritable bowel syndrome: what is the evidence? Nat Rev Immunol. 2022;22(11):674\u201386.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"5095_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13583","volume":"31","author":"J Yang","year":"2019","unstructured":"Yang J, Shang B, Shi H, Zhu S, Lu G, Dai F. The role of toll-like receptor 4 and mast cell in the ameliorating effect of electroacupuncture on visceral hypersensitivity in rats. Neurogastroenterol Motil. 2019;31(6):e13583.","journal-title":"Neurogastroenterol Motil"},{"issue":"9","key":"5095_CR38","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1073\/pnas.91.9.3739","volume":"91","author":"A Leon","year":"1994","unstructured":"Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A. 1994;91(9):3739\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"5095_CR39","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/gut.46.5.670","volume":"46","author":"FF di Mola","year":"2000","unstructured":"di Mola FF, Friess H, Zhu ZW, Koliopanos A, Bley T, Di Sebastiano P, et al. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut. 2000;46(5):670\u20139.","journal-title":"Gut"},{"issue":"2","key":"5095_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0092-8674(95)90168-X","volume":"83","author":"L Aigner","year":"1995","unstructured":"Aigner L, Arber S, Kapfhammer JP, Laux T, Schneider C, Botteri F, et al. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell. 1995;83(2):269\u201378.","journal-title":"Cell"},{"issue":"3","key":"5095_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/BF00688582","volume":"66","author":"T Frykberg","year":"1985","unstructured":"Frykberg T, Esscher T, P\u00e5hlman S, Olsson Y. Neuron-specific enolase as a marker for intestinal neurons. An immunocytochemical study of the human intestinal tract. Acta Neuropathol. 1985;66(3):184\u20137.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"5095_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0024-3205(84)90598-8","volume":"34","author":"MN Sheppard","year":"1984","unstructured":"Sheppard MN, Marangos PJ, Bloom SR, Polak JM. Neuron specific enolase: a marker for the early development of nerves and endocrine cells in the human lung. Life Sci. 1984;34(3):265\u201371.","journal-title":"Life Sci"},{"issue":"10","key":"5095_CR43","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1111\/jgh.15981","volume":"37","author":"X Li","year":"2022","unstructured":"Li X, Ren K, Hong X, Guo S, Yu S, Yang S. Ameliorating effects of electroacupuncture on the low-grade intestinal inflammation in rat model of diarrhea-predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2022;37(10):1963\u201374.","journal-title":"J Gastroenterol Hepatol"},{"key":"5095_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106291","volume":"181","author":"Y Gu","year":"2022","unstructured":"Gu Y, Wang C, Qin X, Zhou B, Liu X, Liu T, et al. Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota. Pharmacol Res. 2022;181:106291.","journal-title":"Pharmacol Res"},{"issue":"17","key":"5095_CR45","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1111\/bph.14396","volume":"175","author":"H Ceuleers","year":"2018","unstructured":"Ceuleers H, Hanning N, Heirbaut J, Van Remoortel S, Joossens J, Van Der Veken P, et al. Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome. Br J Pharmacol. 2018;175(17):3516\u201333.","journal-title":"Br J Pharmacol"},{"key":"5095_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13060811","author":"N Hanning","year":"2021","unstructured":"Hanning N, De Bruyn M, Ceuleers H, Boogaerts T, Berg M, Smet A, et al. Local colonic administration of a serine protease inhibitor improves post-inflammatory visceral hypersensitivity in rats. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13060811.","journal-title":"Pharmaceutics"},{"issue":"5","key":"5095_CR47","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/gut.2007.126680","volume":"57","author":"F Barreau","year":"2008","unstructured":"Barreau F, Salvador-Cartier C, Houdeau E, Bueno L, Fioramonti J. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut. 2008;57(5):582\u201390.","journal-title":"Gut"},{"key":"5095_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042269","author":"SA Scuderi","year":"2022","unstructured":"Scuderi SA, Casili G, Lanza M, Ardizzone A, Pantaleo L, Campolo M, et al. Efficacy of a product containing Xyloglucan and pea protein on intestinal barrier function in a partial restraint stress animal model. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23042269.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5095_CR49","doi-asserted-by":"publisher","first-page":"G42","DOI":"10.1152\/ajpgi.00500.2004","volume":"289","author":"S Bradesi","year":"2005","unstructured":"Bradesi S, Schwetz I, Ennes HS, Lamy CMR, Ohning G, Fanselow M, et al. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol. 2005;289(1):G42\u201353.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"5095_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2014.09.037","volume":"148","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Costinean S, Croce CM, Brasier AR, Merwat S, Larson SA, et al. Microrna 29 targets nuclear factor-\u03baB-repressing factor and Claudin 1 to increase intestinal permeability. Gastroenterology. 2015;148(1):158.","journal-title":"Gastroenterology"},{"issue":"1","key":"5095_CR51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/jam.13320","volume":"122","author":"Y Darbaky","year":"2017","unstructured":"Darbaky Y, Evrard B, Patrier S, Falenta J, Garcin S, Tridon A, et al. Oral probiotic treatment of Lactobacillus rhamnosus Lcr35\u00ae prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress. J Appl Microbiol. 2017;122(1):188\u2013200.","journal-title":"J Appl Microbiol"},{"issue":"4","key":"5095_CR52","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/gut.2007.127068","volume":"57","author":"T Piche","year":"2008","unstructured":"Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Iannelli A, Montoya ML, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 2008;57(4):468\u201373.","journal-title":"Gut"},{"issue":"1","key":"5095_CR53","doi-asserted-by":"publisher","first-page":"11988","DOI":"10.1038\/s41598-020-68961-9","volume":"10","author":"M Singh","year":"2020","unstructured":"Singh M, Singh V, Schurman JV, Colombo JM, Friesen CA. The relationship between mucosal inflammatory cells, specific symptoms, and psychological functioning in youth with irritable bowel syndrome. Sci Rep. 2020;10(1):11988.","journal-title":"Sci Rep"},{"issue":"10","key":"5095_CR54","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrgastro.2014.103","volume":"11","author":"SM Brierley","year":"2014","unstructured":"Brierley SM, Linden DR. Neuroplasticity and dysfunction after gastrointestinal inflammation. Nat Rev Gastroenterol Hepatol. 2014;11(10):611\u201327.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"26","key":"5095_CR55","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","volume":"316","author":"LB Schwartz","year":"1987","unstructured":"Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987;316(26):1622\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"5095_CR56","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/gut.2004.047423","volume":"54","author":"V Morgan","year":"2005","unstructured":"Morgan V, Pickens D, Gautam S, Kessler R, Mertz H. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut. 2005;54(5):601\u20137.","journal-title":"Gut"},{"issue":"1","key":"5095_CR57","doi-asserted-by":"publisher","first-page":"G130","DOI":"10.1152\/ajpgi.00266.2002","volume":"284","author":"HJ Chial","year":"2003","unstructured":"Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol. 2003;284(1):G130-7.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"5095_CR58","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1053\/j.gastro.2017.05.037","volume":"153","author":"DJ Gracie","year":"2017","unstructured":"Gracie DJ, Ford AC. Irritable bowel syndrome-type symptoms are associated with psychological comorbidity, reduced quality of life, and health care use in patients with inflammatory bowel disease. Gastroenterology. 2017;153(1):324\u20135.","journal-title":"Gastroenterology"},{"issue":"7","key":"5095_CR59","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/ajg.2015.128","volume":"110","author":"MI Pinto-Sanchez","year":"2015","unstructured":"Pinto-Sanchez MI, Ford AC, Avila CA, Verdu EF, Collins SM, Morgan D, et al. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol. 2015;110(7):1038\u201348.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"5095_CR60","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/gutjnl-2015-309460","volume":"65","author":"MM Wouters","year":"2016","unstructured":"Wouters MM, Van Wanrooy S, Nguyen A, Dooley J, Aguilera-Lizarraga J, Van Brabant W, et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut. 2016;65(8):1279\u201388.","journal-title":"Gut"},{"key":"5095_CR61","doi-asserted-by":"publisher","unstructured":"Skaper SD. Nerve growth factor: a neuroimmune crosstalk mediator for all seasons. Immunology. 2017;15. https:\/\/doi.org\/10.1111\/imm.12717.","DOI":"10.1111\/imm.12717"},{"issue":"1","key":"5095_CR62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/apt.13848","volume":"45","author":"XJ Xu","year":"2017","unstructured":"Xu XJ, Zhang YL, Liu L, Pan L, Yao SK. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study. Aliment Pharmacol Ther. 2017;45(1):100\u201314.","journal-title":"Aliment Pharmacol Ther"},{"key":"5095_CR63","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.biopha.2018.04.155","volume":"103","author":"Z Guo","year":"2018","unstructured":"Guo Z, Liu Y, Cheng M. Resveratrol protects bupivacaine-induced neuro-apoptosis in dorsal root ganglion neurons via activation on Tropomyosin receptor kinase A. Biomed Pharmacother. 2018;103:1545\u201351.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5095_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0923-1811(99)00065-1","volume":"22","author":"C Pincelli","year":"2000","unstructured":"Pincelli C, Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci. 2000;22(2):71\u20139.","journal-title":"J Dermatol Sci"},{"issue":"11","key":"5095_CR65","doi-asserted-by":"publisher","first-page":"115101","DOI":"10.1088\/0957-4484\/21\/11\/115101","volume":"21","author":"K Matsumoto","year":"2010","unstructured":"Matsumoto K, Sato C, Naka Y, Whitby R, Shimizu N. Stimulation of neuronal neurite outgrowth using functionalized carbon nanotubes. Nanotechnology. 2010;21(11):115101.","journal-title":"Nanotechnology"},{"issue":"8","key":"5095_CR66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1046\/j.1365-2443.2003.00663.x","volume":"8","author":"M Higuchi","year":"2003","unstructured":"Higuchi M, Onishi K, Masuyama N, Gotoh Y. The phosphatidylinositol-3 kinase (PI3K)-Akt pathway suppresses neurite branch formation in NGF-treated PC12 cells. Genes Cells. 2003;8(8):657\u201369.","journal-title":"Genes Cells"},{"key":"5095_CR67","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.neuroscience.2013.09.003","volume":"253","author":"J Hur","year":"2013","unstructured":"Hur J, Jeong HJ, Park J, Jeon S. Chloride channel 4 is required for nerve growth factor-induced TrkA signaling and neurite outgrowth in PC12 cells and cortical neurons. Neuroscience. 2013;253:389\u201397.","journal-title":"Neuroscience"},{"issue":"2","key":"5095_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/CS20050163","volume":"110","author":"MV Chao","year":"2006","unstructured":"Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond). 2006;110(2):167\u201373.","journal-title":"Clin Sci (Lond)"},{"issue":"16","key":"5095_CR69","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.1039\/D1FO01421H","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Li X, Chu J, Shao Y, Sun Y, Zhang Y, et al. Inhibitory effect of Paeoniflorin on IgE-dependent and IgE-independent mast cell degranulation in vitro and vivo. Food Funct. 2021;12(16):7448\u201368.","journal-title":"Food Funct"},{"issue":"2","key":"5095_CR70","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ptr.6531","volume":"34","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang Y, Wang J, Liu R, Zhang G, Dong K, et al. Paeoniflorin inhibits MRGPRX2-mediated pseudo-allergic reaction via calcium signaling pathway. Phytother Res. 2020;34(2):401\u20138.","journal-title":"Phytother Res"},{"issue":"11","key":"5095_CR71","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41401-020-00601-4","volume":"42","author":"J-D Zhang","year":"2021","unstructured":"Zhang J-D, Liu J, Zhu S-W, Fang Y, Wang B, Jia Q, et al. Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation. Acta Pharmacol Sin. 2021;42(11):1821\u201333.","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"5095_CR72","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s13105-022-00938-w","volume":"79","author":"F Ye","year":"2023","unstructured":"Ye F, Lv J, Shen X, Zhang J, Zong Y, Zhu C, et al. Rutin ameliorates inflammatory pain by inhibiting P2X7 receptor in mast cells. J Physiol Biochem. 2023;79(2):287\u201395.","journal-title":"J Physiol Biochem"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05095-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05095-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05095-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:08:14Z","timestamp":1759316894000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05095-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5095"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05095-3","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal Ethics Committee of Guangzhou University of Chinese Medicine (Ethics approval number: 20220510014). The study is reported in accordance with ARRIVE guidelines. All methods were carried out in accordance with relevant guidelines and regulations in the declarations section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}